ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
206.76
-0.13 (-0.06%)
At close: May 8, 2026, 4:00 PM EDT
206.00
-0.76 (-0.37%)
After-hours: May 8, 2026, 7:59 PM EDT
ResMed Stock Forecast
Stock Price Forecast
The 9 analysts that cover ResMed stock have a consensus rating of "Buy" and an average price target of $288.56, which forecasts a 39.56% increase in the stock price over the next year. The lowest target is $227 and the highest is $340.
Price Target: $288.56 (+39.56%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 5 | 5 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $314 → $321 | Buy | Maintains | $314 → $321 | +55.25% | May 1, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $270 → $227 | Hold | Maintains | $270 → $227 | +9.79% | May 1, 2026 |
| Keybanc | Keybanc | Buy Maintains $302 → $290 | Buy | Maintains | $302 → $290 | +40.26% | Apr 27, 2026 |
| JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 15, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $345 → $340 | Strong Buy | Maintains | $345 → $340 | +64.44% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
5.70B
from 5.15B
Increased by 10.80%
Revenue Next Year
6.13B
from 5.70B
Increased by 7.49%
EPS This Year
11.20
from 9.51
Increased by 17.74%
EPS Next Year
12.29
from 11.20
Increased by 9.73%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.0B | 6.5B | |||
| Avg | 5.7B | 6.1B | |||
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.7% | 13.1% | |||
| Avg | 10.8% | 7.5% | |||
| Low | 6.7% | 2.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.79 | 13.21 | |||
| Avg | 11.20 | 12.29 | |||
| Low | 10.14 | 11.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 24.0% | 18.0% | |||
| Avg | 17.7% | 9.7% | |||
| Low | 6.7% | 2.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.